Pregnancy

NGM Bio Announces $122 Million Series A Financing to Initiate Registrational Trial in Primary Sclerosing Cholangitis and Fund Phase 2 Trial in Hyperemesis Gravidarum

The Column Group (TCG) led the round with participation from a select group of investorsPrimary sclerosing cholangitis (PSC) is a…

1 year ago

Season One of ‘Baby Boxes’ is Coming in Hot

Meet the Families Behind Safe Haven Baby BoxesWOODBURN, IN / ACCESSWIRE / July 15, 2024 / Safe Haven Baby Boxes…

1 year ago

Personalized Obesity Care Genetic Testing Available to Women in New Phenomix Sciences and Hello Alpha Partnership

The first-of-its-kind collaboration combines personalized genetic insights with evidence-based treatments to provide accessible and effective obesity care for women MENLO…

2 years ago

Advanced Fertility Center of Texas Has Been Awarded on the Newsweek List of America’s Best Fertility Clinics 2024; Awarded #1 in Texas and #7 Nationwide

Advanced Fertility Center of Texas (AFCT) is proud to announce that it has been recognized on Newsweek and Statista Inc.'s…

2 years ago

ORLADEYO® (berotralstat) Approved in Peru

RESEARCH TRIANGLE PARK, N.C., July 09, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the General Directorate…

2 years ago

TheraNatal Complete Recognized as Top Prenatal Vitamin by The Bump

ROCKVILLE, MD / ACCESSWIRE / July 8, 2024 / Theralogix is proud to announce that TheraNatal® Complete has been featured…

2 years ago

Veru to Participate in the Leerink Therapeutics Forum: I&I and Metabolism

MIAMI, FL, July 02, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on…

2 years ago

Emergent BioSolutions Awarded $250+ Million in Contract Modifications to Supply U.S. Government with Four Critical Medical Countermeasure Products

GAITHERSBURG, Md., July 02, 2024 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced it has received more than…

2 years ago

SNIPR Biome receives funding for the development of CRISPR-medicines to improve Environmental Enteric Dysfunction (EED) in pregnant women

SNIPR BIOME receives funding from the Bill & Melinda Gates Foundation to accelerate the development of SNIPR Biome's microbial gene…

2 years ago

First Patient Enrolled in 60 Degrees Pharmaceuticals Clinical Trial of Tafenoquine for Babesiosis at Tufts Medical Center; First and Only Study of Its Kind

The efficacy and safety of tafenoquine in treating human babesiosis will be evaluated in a randomized, double-blind, placebo-controlled trial conducted…

2 years ago